0001209191-23-012264.txt : 20230223
0001209191-23-012264.hdr.sgml : 20230223
20230223170427
ACCESSION NUMBER: 0001209191-23-012264
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230221
FILED AS OF DATE: 20230223
DATE AS OF CHANGE: 20230223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Young Alethia
CENTRAL INDEX KEY: 0001918147
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40532
FILM NUMBER: 23660773
MAIL ADDRESS:
STREET 1: C/O GRAPHITE BIO, INC.
STREET 2: 201 HASKINS WAY, SUITE 210
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Graphite Bio, Inc.
CENTRAL INDEX KEY: 0001815776
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 844867570
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 HASKINS WAY, SUITE 210
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 484-0886
MAIL ADDRESS:
STREET 1: 201 HASKINS WAY, SUITE 210
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Integral Medicines, Inc.
DATE OF NAME CHANGE: 20200622
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-21
0
0001815776
Graphite Bio, Inc.
GRPH
0001918147
Young Alethia
C/O GRAPHITE BIO, INC.
201 HASKINS WAY, SUITE 210
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Financial Officer
Stock Option (right to buy)
2.18
2023-02-21
4
A
0
220000
0.00
A
2033-02-20
Common Stock
220000
220000
D
1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of January 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date.
/s/ Zed Zduniak, attorney-in-fact
2023-02-23